|
SRRT expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.085800E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.535500E-02 |
| Normal-vs-Stage2 |
3.511400E-01 |
| Normal-vs-Stage3 |
1.783590E-01 |
| Normal-vs-Stage4 |
4.298000E-02 |
| Stage1-vs-Stage2 |
7.098800E-01 |
| Stage1-vs-Stage3 |
5.876000E-01 |
| Stage1-vs-Stage4 |
6.136000E-01 |
| Stage2-vs-Stage3 |
9.778600E-01 |
| Stage2-vs-Stage4 |
5.065800E-01 |
| Stage3-vs-Stage4 |
4.054200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.180570E-01 |
| Normal-vs-AfricanAmerican |
1.403370E-03 |
| Normal-vs-Asian |
9.77009999999501E-05 |
| Caucasian-vs-AfricanAmerican |
3.258600E-03 |
| Caucasian-vs-Asian |
3.124300E-03 |
| AfricanAmerican-vs-Asian |
1.373360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.608200E-01 |
| Normal-vs-Female |
4.174800E-04 |
| Male-vs-Female |
8.28139999999866E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.524800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.254300E-02 |
| Normal-vs-Age(61-80Yrs) |
7.693600E-02 |
| Normal-vs-Age(81-100Yrs) |
6.280600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.399800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.316400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.784000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.105000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.511000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.329400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.87649999997086E-06 |
| Normal-vs-Grade 2 |
2.320300E-02 |
| Normal-vs-Grade 3 |
2.400000E-01 |
| Normal-vs-Grade 4 |
1.336620E-01 |
| Grade 1-vs-Grade 2 |
3.717400E-03 |
| Grade 1-vs-Grade 3 |
2.035800E-04 |
| Grade 1-vs-Grade 4 |
5.302500E-03 |
| Grade 2-vs-Grade 3 |
1.982950E-01 |
| Grade 2-vs-Grade 4 |
8.196600E-01 |
| Grade 3-vs-Grade 4 |
4.876400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.386130E-02 |
| Normal-vs-ccB subtype |
9.061000E-01 |
| ccA subtype-vs-ccB subtype |
1.722860E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.196830E-01 |
| Normal-vs-N1 |
2.143600E-01 |
| N0-vs-N1 |
7.074200E-01 |
|
|
